Trademark: 86756740
Status Date
Monday, November 5, 2018
Filing Date
Tuesday, September 15, 2015
Published for Opposition
Tuesday, February 9, 2016
Abandoned Date
Monday, November 5, 2018
5 Pharmaceutical to act as a prolactin receptor antagonist to treat or prevent diseases, namely, lymphangioleiomymatosis and cancer
Nov 5, 2018
Abandonment Notice Mailed - No Use Statement Filed
Nov 5, 2018
Abandonment - No Use Statement Filed
Mar 27, 2018
Notice Of Approval Of Extension Request E-Mailed
Mar 23, 2018
Extension 4 Granted
Mar 23, 2018
Extension 4 Filed
Mar 23, 2018
Teas Extension Received
Sep 13, 2017
Notice Of Approval Of Extension Request E-Mailed
Sep 11, 2017
Extension 3 Granted
Sep 11, 2017
Extension 3 Filed
Sep 11, 2017
Teas Extension Received
Mar 23, 2017
Notice Of Approval Of Extension Request E-Mailed
Mar 21, 2017
Extension 2 Granted
Mar 21, 2017
Extension 2 Filed
Mar 21, 2017
Teas Extension Received
Sep 16, 2016
Notice Of Approval Of Extension Request E-Mailed
Sep 14, 2016
Extension 1 Granted
Sep 14, 2016
Extension 1 Filed
Sep 14, 2016
Teas Extension Received
Apr 5, 2016
Noa E-Mailed - Sou Required From Applicant
Feb 9, 2016
Official Gazette Publication Confirmation E-Mailed
Feb 9, 2016
Published For Opposition
Jan 20, 2016
Notification Of Notice Of Publication E-Mailed
Jan 4, 2016
Approved For Pub - Principal Register
Dec 30, 2015
Assigned To Examiner
Sep 18, 2015
New Application Office Supplied Data Entered In Tram
Sep 18, 2015
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
